Cargando…
Recent Advances in Vaccine Technologies
This brief review discusses some recent advances in vaccine technologies with particular reference to their application within veterinary medicine. It highlights some of the key inactivated/killed approaches to vaccination, including natural split-product and subunit vaccines, recombinant subunit an...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132473/ https://www.ncbi.nlm.nih.gov/pubmed/29217317 http://dx.doi.org/10.1016/j.cvsm.2017.10.002 |
| _version_ | 1783517444834328576 |
|---|---|
| author | Francis, Michael James |
| author_facet | Francis, Michael James |
| author_sort | Francis, Michael James |
| collection | PubMed |
| description | This brief review discusses some recent advances in vaccine technologies with particular reference to their application within veterinary medicine. It highlights some of the key inactivated/killed approaches to vaccination, including natural split-product and subunit vaccines, recombinant subunit and protein vaccines, and peptide vaccines. It also covers live/attenuated vaccine strategies, including modified live marker/differentiating infected from vaccinated animals vaccines, live vector vaccines, and nucleic acid vaccines. |
| format | Online Article Text |
| id | pubmed-7132473 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71324732020-04-08 Recent Advances in Vaccine Technologies Francis, Michael James Vet Clin North Am Small Anim Pract Article This brief review discusses some recent advances in vaccine technologies with particular reference to their application within veterinary medicine. It highlights some of the key inactivated/killed approaches to vaccination, including natural split-product and subunit vaccines, recombinant subunit and protein vaccines, and peptide vaccines. It also covers live/attenuated vaccine strategies, including modified live marker/differentiating infected from vaccinated animals vaccines, live vector vaccines, and nucleic acid vaccines. Elsevier Inc. 2018-03 2017-12-06 /pmc/articles/PMC7132473/ /pubmed/29217317 http://dx.doi.org/10.1016/j.cvsm.2017.10.002 Text en © 2017 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Francis, Michael James Recent Advances in Vaccine Technologies |
| title | Recent Advances in Vaccine Technologies |
| title_full | Recent Advances in Vaccine Technologies |
| title_fullStr | Recent Advances in Vaccine Technologies |
| title_full_unstemmed | Recent Advances in Vaccine Technologies |
| title_short | Recent Advances in Vaccine Technologies |
| title_sort | recent advances in vaccine technologies |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132473/ https://www.ncbi.nlm.nih.gov/pubmed/29217317 http://dx.doi.org/10.1016/j.cvsm.2017.10.002 |
| work_keys_str_mv | AT francismichaeljames recentadvancesinvaccinetechnologies |